Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the E...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

Celebrating Mayo’s win from Ma...

01:07:54

Celebrating Mayo’s win from MacHale Park! - GAA Panel

The Hard Shoulder

01:07:54


Kids Clinic: The impact of scr...

00:07:19

Kids Clinic: The impact of screens on developing brains

The Hard Shoulder

00:07:19


Mayo fans celebrate the win! -...

00:07:12

Mayo fans celebrate the win! - Henry McKean Reports

The Hard Shoulder

00:07:12


What would a waste collection...

00:08:04

What would a waste collection system overhaul look like?

The Hard Shoulder

00:08:04